Bepirovirsen is an effective antiviral drug for the treatment of chronic hepatitis B.
GlaxoSmithKline
Posted inCOVID-19, Infections, Research
Omicron Treatment: Most Effective Drugs
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine
Innovative Medicago’s vaccine is made by molecular pharming technology.
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Posted inClinical Trials, COVID-19, Infections
Ensovibep: Drug for All Variants of Coronavirus Including Omicron
Molecular Partners and Novartis believe in the success of DARPins.